'); } else { var query = elem.find('.keywords').html(); $.ajax({ context: elem, url: 'https://wn.com/api/upge/cheetah-search-adv/video', cache: true, data: { 'query': query }, dataType: 'jsonp', success: function(text) { if (text.length > 0) { video_id = text[0].id; elem.find('.player').html(''); } } }); } } var stopAllYouTubeVideos = function() { var iframes = document.querySelectorAll('iframe'); Array.prototype.forEach.call(iframes, function(iframe) { iframe.contentWindow.postMessage(JSON.stringify({ event: 'command', func: 'pauseVideo' }), '*'); }); } jQuery(function() { jQuery(".playVideo").live("click", function() { if(!$(this).hasClass("played")){ stopAllYouTubeVideos(); var elem = $(this); setTimeout(function(){ mouseOverMe(elem); }, 1000); } }); jQuery(".description_box .expandContent").live("click", function() { elem = $(this).parent().parent().parent().find('.descContent'); if(elem.height() > 51) { elem.css('height', '44px'); $(this).html('Show More '); }else{ elem.css('height', 'auto'); $(this).html('Hide '); } }); jQuery('.interview-play-off').click(function() { $(".interview-play-off").hide(); $(".interview-play").show(); $(".videoplayer-control-pause").click(); }); jQuery(".video-desc .show_author_videos").live("click", function() { query = $(this).attr('title'); container = $(this).parent().parent().parent().find('.video-author-thumbs'); $(this).parent().parent().parent().find('.video-author-thumbs').css('height', '220px'); jQuery.ajax({ url: '/api/upge/cheetah-photo-search/videoresults', data: {'query': query}, success: function(text) { if(!text) { text = i18n("No results"); } container.html(jQuery(text)); } }); }); }); // -->

Latest News for: biogen

Edit

Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics

PR Newswire 25 Mar 2026
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 ... 196170) announced today that it has entered into an exclusive license agreement with Biogen Inc.
Edit

Cutaneous Lupus Erythematosus Market: Accelerating Growth and Pipeline Impact by 2034 – DelveInsight | Biogen, ...

GetNews 24 Mar 2026
In January 2026, Biogen Inc ... Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen, Biogen, Gilead Sciences, Pfizer, Bristol-Myers Squibb, Novartis, Rigel Pharmaceuticals, Merck, and others ... Biogen ... Biogen.
Edit

Management Change/Compensation (Form 8-K) (Biogen Inc)

Public Technologies 11 Mar 2026
On March 11, 2026, Biogen Inc. (the "Company") announced that Susan H ... Attachments Original document Permalink. Disclaimer. Biogen Inc ... (noodl. 130104559) .
Edit

Biogen to Participate in the Stifel 2026 Virtual CNS Forum (Biogen Inc)

Public Technologies 10 Mar 2026
Cambridge, MA, - - Biogen Inc ... To access the live webcast, please visit the Investors section of Biogen's website at investors.biogen.com ... About Biogen ... We routinely post information that may be important to investors on our website at www.biogen.com.
Edit

Aduhelm (Biogen, Eisai) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, ...

Nasdaq Globe Newswire 10 Mar 2026
Advances in monoclonal antibody treatments and a focus on self-injectable formulations further drive market growth ... .
Edit

Svante & Integrated Packaging Company Advance U.S. Biogenic CDR Project to Feasibility (Svante Inc)

Public Technologies 10 Mar 2026
The bioenergy with carbon capture (BECCS) project aims to remove more than 500,000 tonnes per year of biogenic CO2 emissions from a U.S ... tonnes per year of biogenic CO₂ generated from mill operations.
Edit

From Science to Impact with Biogen CEO Chris Viehbacher

CNBC 05 Mar 2026
Biogen is sharpening its long-term strategy to lead in the next era of innovation, ...
Edit

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome (Biogen Inc)

Public Technologies 04 Mar 2026
From time to time, we have used, or expect in the future to use, our investor relations website (investors.biogen.com), the Biogen LinkedIn account (linkedin.com/company/biogen-) and the Biogen X ...
Edit

Biogen to Participate in the Leerink Global Healthcare Conference 2026 (Biogen Inc)

Public Technologies 03 Mar 2026
Cambridge, MA, - - Biogen Inc ... BIIB) announced today that Uptal Patel, Head of Biogen West Coast Hub, will participate in a fireside chat during the Leerink Global Healthcare Conference 2026 ... About Biogen ... Biogen ... Biogen Inc.
×